We represented Triple Tree Capital Partners and Vestar Capital Partners in the merger of their respective portfolio companies, The Emily Program and Veritas Collaborative. The Emily Program provides individualized care for people with eating disorders of all ages and genders leading to recovery from eating disorders. Veritas Collaborative is a national healthcare system for the treatment of eating disorders. Terms of the transaction were not disclosed.
The Emily Program and Veritas Collaborative Merger
You Also May Be Interested In:
ALS Education’s Charter School Management Business Sold to Satori Capital, Epic Partners Backed Company
Representation of LFM Capital’s portfolio company, J&E Precision Tool, in its acquisition of Beranek, LLC, a precision manufacturer of technical components for the aerospace & defense, and space exploration markets
Lead Counsel to POINT Biopharma Inc. in its Proposed SPAC Business Combination with Research Alliance Corp. I
Lead Counsel to POINT Biopharma Inc. in connection with its proposed SPAC business combination with Therapeutics Acquisition Corp. d/b/a Research Alliance Corp. I (Nasdaq: RACA), a special purpose acquisition company, sponsored by RA Capital Management. Upon closing, the combined company will be named POINT Biopharma Global Inc. and is expected to be listed on Nasdaq under the ticker symbol “PNT”.